4Filed Aug 12, 8:00 PM ET

Strata Critical Medical (SRTA) Director Reginald Love Sells 5,091 Shares

$SRTA · Strata Critical Medical, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Strata Critical Medical (SRTA) Director Reginald Love Sells 5,091 Shares

What Happened

  • Reginald Love, a director of Strata Critical Medical, reported a sale of 5,091 common shares on Aug 10, 2026. The shares were disposed at $5.75 per share for a total transaction value of $29,273. The filing characterizes the transaction as an open-market or private sale (code S).
  • This was a sale (not a purchase); sales are often routine (e.g., portfolio rebalancing or liquidity needs) and do not necessarily indicate a change in the insider’s view of the company.

Key Details

  • Transaction date: 2026-08-10; Filing date: 2026-08-13 (Form 4 accession 0001628280-26-056841).
  • Price per share: $5.75; Shares sold: 5,091; Gross proceeds: $29,273.
  • Transaction type/code: Sale (S) — reported as "open market or private sale."
  • Shares owned after the transaction: Not specified in the provided excerpt of the filing.
  • No footnotes, 10b5-1 plan, option exercise, or tax-withholding details were included in the provided data.

Context

  • For retail investors: insider sales are common and can reflect personal liquidity needs or diversification; they are generally less informative than insider purchases, which may signal confidence. This single modest sale (≈$29K) should be considered alongside other insider activity and company developments.